19-45529065-G-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7

The NM_001017989.3(OPA3):​c.534C>G​(p.Ser178Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,447,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. S178S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

OPA3
NM_001017989.3 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.52

Publications

0 publications found
Variant links:
Genes affected
OPA3 (HGNC:8142): (outer mitochondrial membrane lipid metabolism regulator OPA3) The mouse ortholog of this protein co-purifies with the mitochondrial inner membrane. Mutations in this gene have been shown to result in 3-methylglutaconic aciduria type III and autosomal dominant optic atrophy and cataract. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
OPA3 Gene-Disease associations (from GenCC):
  • optic atrophy 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • 3-methylglutaconic aciduria type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP7
Synonymous conserved (PhyloP=-1.52 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001017989.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPA3
NM_001017989.3
c.534C>Gp.Ser178Ser
synonymous
Exon 2 of 2NP_001017989.2Q9H6K4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPA3
ENST00000323060.4
TSL:1
c.534C>Gp.Ser178Ser
synonymous
Exon 2 of 2ENSP00000319817.3Q9H6K4-2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.91e-7
AC:
1
AN:
1447126
Hom.:
0
Cov.:
30
AF XY:
0.00000139
AC XY:
1
AN XY:
718148
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33056
American (AMR)
AF:
0.00
AC:
0
AN:
43334
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25494
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39460
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84996
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51756
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4860
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1104552
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59618
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.27
DANN
Benign
0.53
PhyloP100
-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1162879805; hg19: chr19-46032323; API